Hip replacement patients may need less blood loss with right drug dose
NCT ID NCT03822793
First seen Jan 04, 2026 · Last updated Apr 24, 2026 · Updated 17 times
Summary
This study looked at 170 adults having hip replacement surgery to find the best dose of tranexamic acid, a drug that reduces bleeding. Participants received a single dose before surgery, and researchers measured how much their hemoglobin (a blood protein) dropped. The goal is to minimize blood loss and the need for transfusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHROPATHY OF HIP are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Saint-Etienne
Saint-Etienne, France
Conditions
Explore the condition pages connected to this study.